简
/
繁
/
EN
About Us
R&D
Products
News
Careers
Investors
Contact us
Investors
（02186.HK）
HK$
➚
%
Volume(M)
0thousand
Turnover(HK $)
0thousand
Data as of：
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Year
2022
2023
2024
2025
2026
27
2023-03
Terms of Reference of the Environmental, Social and Governance Committee of the Board
27
2023-03
List of Directors and their Roles and Functions
21
2023-03
Voluntary Announcement Acceptance of BLA in China for the Group's Denosumab Injection (BA1102) for the Onocology Indications
13
2023-03
Voluntary Announcement Patient Enrollment Completed in the Phase 3 Clinical Study of BA9101 in China
10
2023-03
Notice of Board Meeting
01
2023-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
12
2023-02
List of Directors and their Roles and Functions
12
2023-02
Passing Away of a Non-Executive Director
06
2023-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
25
2023-01
Stabilizing Actions, End of Stabilization Period and Lapse of the Over-Allotment Option
12
13
14
15
16
Follow me
鲁公网安备37069102000284